0.56
+0.01(+1.82%)
Currency In CAD
Sector
Healthcare
Industry
Biotechnology
Employees
N/A
First IPO Date
January 07, 2008
| Name | Title | Pay | Year Born |
| Francis Gleeson | Co-Founder, Chief Executive Officer, President & Director | 267,788 | 1955 |
| Michael Liggett | Strategic Advisor | 44,483 | 1960 |
| Philip Lambert | Chief Scientific Officer | 67,403 | 1968 |
| Michael A. Rudnicki | Co-Founder & Chief Discovery Officer | 120,000 | 1962 |
| Warren Whitehead | Head of Corporation Strategy | 120,000 | 1952 |
| Elizabeth Williams | Chief Financial Officer | 120,000 | 1978 |
| William Wasyl Jarosz | Executive Director | 193,789 | 1956 |
| Desiree Chan | Chief of Staff | 0 | N/A |
| Michael Cross | Chief Business Officer | 0 | 1965 |
| J. Robert Hall | Senior Vice President of Finance & Administration | 0 | N/A |
Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics to treat degenerative muscle diseases. Its lead program focuses on the development of oral therapeutic drug to correct muscle stem cell polarity and restore the body's innate muscle repair and regeneration process. The company was incorporated in 2012 and is headquartered in Toronto, Canada.